Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed · Phase 2

Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving topotecan in different dosing schedules may kill more tumor cells. PURPOSE: This phase II trial is studying how well topotecan works in treating patients with recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer.

Key facts

Study ID

NCT00114166

Run by

Gynecologic Oncology Group

People needed

81

Starts

2005-01-01

Last updated by the study team

2018-07-24

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus — New Britain, Connecticut, United States
• Tunnell Cancer Center at Beebe Medical Center — Lewes, Delaware, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Washington Cancer Institute at Washington Hospital Center — Washington D.C., District of Columbia, United States
• MBCCOP - Medical College of Georgia Cancer Center — Augusta, Georgia, United States
• Rush-Copley Cancer Care Center — Aurora, Illinois, United States
• University of Illinois Cancer Center — Chicago, Illinois, United States
• Rush University Medical Center — Chicago, Illinois, United States
• Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
• Joliet Oncology-Hematology Associates, Limited - West — Joliet, Illinois, United States
• Advocate Lutheran General Cancer Care Center — Park Ridge, Illinois, United States
• Carle Cancer Center at Carle Foundation Hospital — Urbana, Illinois, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• Saint Anthony Memorial Health Centers — Michigan City, Indiana, United States
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• Woman's Hospital — Baton Rouge, Louisiana, United States
• Union Hospital Cancer Program at Union Hospital — Elkton, Maryland, United States
• Tufts-NEMC Cancer Center — Boston, Massachusetts, United States
• UMASS Memorial Cancer Center - University Campus — Worcester, Massachusetts, United States
• Saint Joseph Mercy Cancer Center — Ann Arbor, Michigan, United States
• CCOP - Michigan Cancer Research Consortium — Ann Arbor, Michigan, United States
• Oakwood Cancer Center at Oakwood Hospital and Medical Center — Dearborn, Michigan, United States
• Genesys Hurley Cancer Institute — Flint, Michigan, United States
• Hurley Medical Center — Flint, Michigan, United States
• Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.